Insider Transactions in Q4 2021 at Biomarin Pharmaceutical Inc (BMRN)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2021
|
Jean Jacques Bienaime Director |
BUY
Small Acquisition
|
Direct |
100
+0.03%
|
$8,900
$89.22 P/Share
|
|
Dec 16
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
6,000
-1.94%
|
$504,000
$84.68 P/Share
|
|
Dec 16
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+1.9%
|
$222,000
$37.46 P/Share
|
|
Dec 15
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
6,000
-1.94%
|
$492,000
$82.71 P/Share
|
|
Dec 15
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+1.9%
|
$222,000
$37.46 P/Share
|
|
Dec 10
2021
|
Jean Jacques Bienaime Director |
SELL
Bona fide gift
|
Direct |
700
-0.23%
|
-
|
|
Dec 01
2021
|
Jean Jacques Bienaime Director |
SELL
Open market or private sale
|
Direct |
1,500
-0.49%
|
$130,500
$87.22 P/Share
|
|
Oct 26
2021
|
Jeffrey Robert Ajer EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,739
-4.67%
|
$199,947
$73.6 P/Share
|
|
Oct 20
2021
|
Jean Jacques Bienaime Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.33%
|
$37,000
$37.46 P/Share
|